Mini, a diabetic, was 55 years old when she made a trip to the hospital for a routine eye examination despite having normal ...
Three of the most widely prescribed semaglutide drugs, Ozempic, Rybelsus, and Wegovy, are now linked to reports of sudden ...
OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye ...
Many of the world's leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...
Ticks are small, and you might not notice when they bite, but the diseases they carry can dramatically harm your health. Each ...
(RGNX) tumbled 15% after-hours on Thursday after the company announced plans to raise $100 million through a public stock ...
Researchers keep human retinas responsive to light for 10 hours after death in a breakthrough that could advance treatments ...
Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...
Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a development-stage biomedical company advancing topical metformin-based ophthalmic therapies for degenerative eye diseases, ...
Glaucoma and Cataract are two distinct diseases of the eye but are often confused due to similar terminology of motia in ...